| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2025/03/04 | 06 : 22 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2025/03/01 | 06 : 31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2025/03/01 | 06 : 30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2025/03/01 | 06 : 29 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2025/03/01 | 06 : 28 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2025/02/19 | 21 : 01 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2025/02/19 | 20 : 58 | Business Wire | Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2025/02/06 | 21 : 00 | Business Wire | Bausch + Lomb Provides Update on Potential Sale | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2025/01/22 | 21 : 00 | Business Wire | Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19 | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2025/01/13 | 21 : 00 | Business Wire | Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2025/01/13 | 20 : 00 | Business Wire | Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2025/01/07 | 21 : 00 | Business Wire | Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2025/01/02 | 21 : 00 | Business Wire | Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/12/27 | 06 : 19 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/12/27 | 06 : 16 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/12/27 | 06 : 14 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/12/12 | 21 : 00 | Business Wire | Bausch + Lomb Responds to Rumors of a Potential Sale | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/12/11 | 20 : 59 | Business Wire | Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/11/14 | 21 : 00 | Business Wire | Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/11/02 | 05 : 27 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/10/31 | 05 : 32 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/10/30 | 20 : 04 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/10/30 | 20 : 00 | Business Wire | Bausch + Lomb Announces Third-Quarter 2024 Results | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/10/14 | 20 : 00 | Business Wire | Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/10/09 | 21 : 00 | Business Wire | Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30 | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/10/01 | 20 : 00 | Business Wire | Bausch + Lomb Launches Opal™ Digital Marketplace in the United States | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/09/17 | 19 : 42 | IH Market News | Investors Anticipate Retail Sales Data and Fed Decision; Oil Prices Dip as Investors Weigh U.S. Production | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/08/07 | 06 : 49 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/08/02 | 05 : 48 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NYSE:BLCO | Bausch plus Lomb Corporation |
| 2024/08/02 | 05 : 17 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NYSE:BLCO | Bausch plus Lomb Corporation |
